Halifax, Canada Clinical Trials

L Laura Hamilton

Reversal of Atrial Substrate to Prevent Atrial Fibrillation Cohort Study

Atrial fibrillation (AF) is a major health problem, with a prevalence of 0.4-1% of the population. It results in high healthcare costs and significant morbidity, especially for patients with severe symptoms. The RASTA-AF randomized control trial (RCT) is designed to answer the following question: does vigorous treatment of AF with …